Zobrazeno 1 - 5
of 5
pro vyhledávání: '"YI-JU ZHAO"'
Autor:
Yongtao Wen, Qingling Guo, Yi-ju Zhao, Chenli Xie, Lei Yang, Sufen Zeng, Yuanbin Liu, Lichong Chen, Fuman Qiu, Qiu-ting Liang, Jiachun Lu
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND The prevalence of bronchiectasis with comorbid chronic obstructive pulmonary disease (COPD) is rising, which causes extremely high risk of exacerbation and mortality. We aimed to evaluate the differences in clinicopathological manifestatio
Autor:
Yen Pei C. Chang, John Shelton, Yi-Ju Zhao, Jeffery R. O'Connell, Xiaolian Shi, Jing Yin, Sandra Ott, Coleen M. Damcott, Evadnie Rampersaud, Braxton D. Mitchell, Li Zhang, Mao Fu, Haiqing Shen, Patrick F. McArdle, Alan R. Shuldiner
Publikováno v:
Diabetes. 56:3053-3062
OBJECTIVE— We sought to identify type 2 diabetes susceptibility genes through a genome-wide association scan (GWAS) in the Amish. RESEARCH DESIGN AND METHODS— DNA from 124 type 2 diabetic case subjects and 295 control subjects with normal glucose
Publikováno v:
Journal of Applied Physiology. 81:2595-2603
Zhao, Yi-Ju, Jian Wang, Mary L. Tod, Lewis J. Rubin, and Xiao-Jian Yuan. Pulmonary vasoconstrictor effects of prostacyclin in rats: potential role of thromboxane receptors. J. Appl. Physiol. 81(6): 2595–2603, 1996.—Endogenous prostacyclin (PGI2;
Autor:
Ruth E. Pakyz, Mary Ann Drolet, Alan R. Shuldiner, Paul Sack, William R. Herzog, Kathleen A. Ryan, Sylvia Newcomer, Haiqing Shen, Yi-Ju Zhao, Braxton D. Mitchell, Xiaolian Shi, Heidi Karon
This study was designed to determine the factors that contribute to interindividual variation in the antiplatelet effects of aspirin. We measured platelet response to aspirin in 745 (400 men and 345 women) drug-naive asymptomatic subjects of the Here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97eb94ee7128944b0df737eb540bc133
https://europepmc.org/articles/PMC3674572/
https://europepmc.org/articles/PMC3674572/
Publikováno v:
Experimental lung research. 24(1)
Increase in intracellular adenosine 3', 5'-cyclic monophosphate (cAMP) is a common pathway for many clinically used drugs to cause pulmonary artery (PA) relaxation. Activity of sarcolemmal K+ and Cl(-)-channels is an important determinant of membrane